These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21039543)

  • 1. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier.
    Kanzer J; Tho I; Flaten GE; Mägerlein M; Hölig P; Fricker G; Brandl M
    J Pharm Pharmacol; 2010 Nov; 62(11):1591-8. PubMed ID: 21039543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability.
    Flaten GE; Skar M; Luthman K; Brandl M
    Eur J Pharm Sci; 2007 Mar; 30(3-4):324-32. PubMed ID: 17204409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants.
    Fischer SM; Flaten GE; Hagesæther E; Fricker G; Brandl M
    J Pharm Pharmacol; 2011 Aug; 63(8):1022-30. PubMed ID: 21718285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes.
    Flaten GE; Bunjes H; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jul; 28(4):336-43. PubMed ID: 16697561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.
    Fischer SM; Buckley ST; Kirchmeyer W; Fricker G; Brandl M
    Int J Pharm; 2012 Jan; 422(1-2):52-8. PubMed ID: 22027395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.
    Flaten GE; Luthman K; Vasskog T; Brandl M
    Eur J Pharm Sci; 2008 Jul; 34(2-3):173-80. PubMed ID: 18499410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.
    Kleberg K; Jacobsen J; Müllertz A
    J Pharm Pharmacol; 2010 Nov; 62(11):1656-68. PubMed ID: 21039549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of vesicle electrokinetic chromatography as an in vitro assay for the estimation of intestinal permeability of pharmaceutical drug candidates.
    Pascoe RJ; Masucci JA; Foley JP
    Electrophoresis; 2006 Feb; 27(4):793-804. PubMed ID: 16411277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
    Tiemessen H; van Hoogevest P; Leigh ML
    Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.
    Dai WG; Dong LC; Li S; Pollock-Dove C; Chen J; Mansky P; Eichenbaum G
    Int J Pharm; 2007 May; 336(1):1-11. PubMed ID: 17178444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous drug dispersions with mono- and diacyl lecithin: On molecular categorization of their feasibility and UV dissolution imaging.
    Gautschi N; Van Hoogevest P; Kuentz M
    Int J Pharm; 2015 Aug; 491(1-2):218-30. PubMed ID: 26129840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of water and its effect on drug delivery. A commentary.
    Loftsson T; Brewster ME
    Int J Pharm; 2008 Apr; 354(1-2):248-54. PubMed ID: 17920796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.